Welcome! Log into your account
Forgot your password? Get help
Recover your password
A password will be e-mailed to you.
EMA Has Started a Review of The Multiple Sclerosis Medicine Lemtrada
EMA has started a review of the multiple sclerosis medicine Lemtrada (alemtuzumab) following new reports of immune-mediated conditions (caused by the body’s defence system not working properly) and pr...
Pharmasyntez Group of Companies
Rafarma – a full cycle pharmaceutical enterprise
Binnopharm – full-cycle biopharmaceutical faciliti...
Pharmacor Production Ltd.
R-Pharm – Russian High-Tech Pharmaceutical Enterprise
PIQ-PHARMA Group of Companies
Top 30 pharmaceutical contract manufacturing organisations
GMP Inspection practice: a case for global benchmarking, con...
Merck KGaA will lead Global Oncology Big Data Alliance
The Power of Steam: How to Remove Residues of Collagen from ...
Merck and Utah University Found Potential Drug Target for Di...
Cell Research of Russian, Chinese and American Scientists
Subscribe to Newsletter!
© GMP news